apl. Prof. Dr. Christian Ott



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Neurogenic tachykinin mechanisms in experimental nephritis of rats (2020) Rodionova K, Hilgers KF, Paulus EM, Tiegs G, Ott C, Schmieder R, Schiffer M, et al. Journal article High Sodium Diet - Role in Renal Sympathodepression (2020) Rodionova K, Ditting T, Fahrmeier F, Ott C, Schmieder R, Schiffer M, Amann KU, Veelken R Conference contribution Influence of Age on Upper Arm Cuff Blood Pressure Measurement (2020) Picone DS, Schultz MG, Otahal P, Black JA, Bos WJ, Chen CH, Cheng HM, et al. Journal article Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes (2019) Jung S, Bosch A, Kannenkeril D, Karg M, Striepe K, Bramlage P, Ott C, Schmieder R Conference contribution Tissue sodium concentration emerged as a determinant of hypertrophic vascular remodeling in type 2 diabetes (2019) Schmieder R, Jung S, Kannenkeril D, Harazny JM, Striepe K, Ott C, Linz P, et al. Conference contribution Tissue sodium concentration correlates with hypertrophic vascular remodelling in type 2 diabetes (2019) Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Linz P, Nagel AM, et al. Conference contribution Pleiotropic effects under combined therapy with empagliflozin and linagliptin compared to metformin and insulin glargine in patients with type 2 diabetes (2019) Jung S, Ott C, Kannenkeril D, Bosch A, Karg M, Striepe K, Bramlage P, Schmieder R Conference contribution Disparate effects of the combined therapy of empagliflozin and linagliptin versus metformin and insulin glargine on renal haemodynamics in type 2 diabetes (2019) Ott C, Jung S, Kannenkeril D, Striepe K, Bosch A, Korn M, Bramlage P, Schmieder R Conference contribution EFFECTS OF RENAL DENERVATION IN PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE: UPDATED DATA FROM THE GLOBAL SYMPLICITY REGISTRY WITH FOLLOW-UP OF 3 YEARS (2019) Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Schlaich MP, Williams B, et al. Conference contribution VASCULAR REMODELING OF RETINAL VESSELS IN PATIENTS WITH CONGESTIVE HEART FAILURE (2019) Jung S, Kannenkeril D, Ott C, Cifkova R, Harazny JM, Schmieder R Conference contribution